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Abstract
Background The heterogeneous patterns and trends in
tobacco consumption contribute to regional and gender
differences in the burden of gastric cancer attributable to
smoking.
Aims To estimate the proportion and absolute number of
gastric cancer cases that can be attributed to smoking in
different countries, in 2012 and 2020.
Methods Population attributable fractions (PAFs) were
computed for 118 countries, using data of smoking
prevalence in 2002 and 2011 and published estimates of the
magnitude of the association between smoking and gastric
cancer, assuming a time lag of &10 years.
Results For men, the highest PAF estimates in 2012 were
observed in Eastern Asia and the lowest in North America,
whereas for women the highest were in Western Europe
and the lowest in Africa. Very high Human Development
Index (HDI) countries presented the lowest median PAF in
men (very high vs. high, medium, and low HDI: 17.2 vs.
20.8 %, p = 0.014) and the highest median PAF in women
(very high vs. high, medium, and low HDI: 4.3 vs. 1.8 %,
p\ 0.001). Estimates for 2020 show a decrease in median
PAFs, but the estimated absolute number of cases at-
tributable to smoking in the countries analyzed increased
for men (&154,000 vs. &160,000) and decreased for
women (&6200 vs. &5600).
Conclusions Smoking accounts for a larger number of
gastric cancer cases among men, and gender differences are
expected to increase in the next decade, despite the de-
crease in PAFs. Intensified efforts to control smoking are
needed to further reduce the burden of gastric cancer.
Keywords Smoking  Stomach neoplasms  Population
attributable fractions  Predictions
Introduction
Gastric cancer is the fifth most common malignancy and
the third leading cause of cancer death worldwide [1],
despite the sustained decline of gastric cancer rates over the
past several decades [2, 3]. The apparent potential for an
even greater decrease without specific interventions to
control its main determinants contributes to the misper-
ception that this is no longer a public health problem, at
least in more developed countries. However, in the most
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recent years, the relative declines were smaller in several
settings, and a leveling off is already expected in a few
countries [4].
Consumption of salt, fruit, and vegetable were the first
exposures to be associated with gastric cancer [5, 6], but
the evidence currently available shows a lack of consistent
results and a weaker effect than initially thought [7, 8],
whereas Helicobacter pylori infection joined the gastric
carcinogenic model more lately [9, 10], and the association
may be stronger than expected [11]. More recently, gastric
cancer has been classified as a tobacco-related cancer [12],
and smoking control policies are also expected to influence
the burden of this frequent oncologic disease.
Given the heterogeneous patterns and trends in smoking
across countries from different world regions and with
distinct levels of economic development [13, 14], we
aimed to estimate, for a large number of countries world-
wide, the proportion and absolute number of gastric cancer
cases that can be attributed to smoking in 2012, and the
corresponding figures expected for 2020.
Methods
Population attributable fractions (PAFs), i.e., estimates of
the proportion of gastric cancer cases that can be attributed
to smoking, were computed for different countries, ac-
cording to sex. For this, we used country-specific data on
smoking prevalence and gastric cancer incidence and
published estimates of the magnitude of the association
between smoking and gastric cancer. A time lag of ap-
proximately 10 years was assumed, based on the stronger
associations observed between smoking and cancer or in-
testinal metaplasia [15, 16] than with the preceding gastric
lesions, indicative of an effect later in carcinogenesis.
Estimates of PAF and the absolute number of cases at-
tributable to smoking in each country were computed for
those with sex-specific data available for both the preva-
lence of smoking in 2002 and 2011 and gastric cancer
incidence in 2012 and projections for 2020.
Association Between Smoking and Gastric Cancer
We conducted a systematic review of meta-analyses to
obtain estimates of the magnitude of association between
smoking and gastric cancer by sex. Seventy-two references
were retrieved through PubMed search, from inception to
July 2014, and backward citation tracking. Six meta-ana-
lyses were identified [15, 17–21], and data extraction was
accomplished following a protocol defined a priori. A de-
tailed description of the published meta-analyses is pro-
vided in Supplemental Table 1 and the results in Fig. 1.
Only two meta-analyses presented the results separately
by sex [15, 19]; however, one of them was restricted to
studies evaluating Japanese populations living in Japan
[19]. Therefore, we selected the results from a meta-ana-
lysis [15] including cohort studies conducted worldwide; to
compute PAFs, we used sex-specific estimates of the
relative risk (RR) for the comparison of current smokers
with never smokers (men: 1.62; women: 1.20).
Prevalence of Smoking
Smoking prevalence in 2002 [22] and 2011 [23], separately
for men and women aged 15 years or older, was retrieved
from two World Health Organization (WHO) sources. Data
were available for 144 and 166 countries, respectively, for
2002 and 2011.
Calculation of PAFs
We estimated the proportional reduction in gastric cancer
incidence that would arise if exposure to smoking corre-
sponded to a counterfactual distribution scenario, defined
as the exposure distribution that would result in the lowest
population risk (e.g., the whole population being lifelong
non-smokers). We used the method proposed by Levin [24]
and computed PAF using the following equation:
PAF ¼ PðRR 1Þ
PðRR 1Þ þ 1
where P is the prevalence of smoking, and RR is the
relative risk of the association between smoking and gastric
cancer.
Gastric Cancer Incidence
Estimates of the number of new gastric cancer cases in
2012 and predictions for 2020 for men and women were
retrieved from GLOBOCAN 2012 [1], for 118 of the
countries with available data on the prevalence of smoking.
This was used to compute the absolute number of cases
attributable to smoking in these countries, for both periods.
Results
There were wide geographical and gender differences in
PAFs in 2012 (Fig. 2 and Supplemental Tables 2 and 3). In
all countries, PAFs were higher for men, among whom the
lowest median estimates were observed in North America
and the highest in Eastern Asia; the absolute number of cases
attributable to smoking reached more than 18,000 in Japan
and 80,000 in China. For women, the highest median PAFs
were found in Western Europe and the lowest in Africa.
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Figure 3 presents PAF estimates according to the levels
of Human Development Index (HDI) in 2012 [25]. Coun-
tries with high, medium, and low HDI presented similar
median PAFs, both among men and women. Very high
HDI countries had the lowest median PAF in men (very
high vs. high, medium, and low HDI: 17.2 vs. 20.8 %,
p = 0.014) and the highest median PAF in women (very
high vs. high, medium, and low HDI: 4.3 vs. 1.8 %,
p\ 0.001).
Between 2012 and 2020, estimates show a decrease in
the median PAF, both in men (from 19.5 to 16.5 %) and in
women (from 3.0 to 1.9 %); nevertheless, there were sev-
eral countries, with different levels of HDI, depicting in-
creases in PAFs, except among women from low HDI
settings (Fig. 4). In the settings where PAFs were estimated
to decrease in this period, the percent variation tended to be
more pronounced among women, and the absolute number
of cases increased in only a few of these countries. In men,
the proportional declines in PAFs were usually smaller
than 25 % and the estimated number of cases increased in a
greater number of these countries (Fig. 4).
In the 118 countries analyzed, the absolute number of
gastric cancer cases attributable to smoking increased from
&154,000 in 2012 to &160,000 in 2020 among men and
decreased from &6200 in 2012 to &5600 in 2020 among
women. The most pronounced changes were a decrease in
&4000 cases in Japan and an increase in &8000 cases in
China, among men.
Discussion
The proportion of gastric cancer cases that can be attributed
to smoking differs substantially between men and women
and across countries with different levels of development,
as expected when taking into account the gender and re-
gional differences in the prevalence of smoking.
Previous analyses have shown variation according to
sex, with 13–16 % of gastric cancer cases being attributed
to smoking in men and 4–7 % in women [21, 26]. Direct
comparisons with our results are difficult due to differences
in the periods and regions covered by different studies on
Fig. 1 Meta-analyses [identified through PubMed search, from
inception to July 2014, using the following expression: (gastric OR
stomach) AND cancer AND (smoking OR tobacco OR cigarette) AND
(‘‘systematic review’’ OR meta-analysis OR ‘‘combined analysis’’ OR
‘‘pooled analysis’’). Full papers published in English, Portuguese,
Spanish, French, Italian, and Polish were evaluated. Screening of
reference lists and data extraction were accomplished independently
by two researchers (BP and CC), following a protocol defined a priori,
and discrepancies were discussed until consensus or resolved
involving a third researcher (NL)] on the association between
smoking and gastric cancer
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this topic. The burden of gastric cancer attributable to
smoking has also been shown to differ with socioeconomic
status at country level, being higher in more developed
countries compared with those less developed (14 vs. 9 %
[21], 25 vs. 11 % [27], or 23 vs. 9 % [26]). Our results
confirm previous observations and depict more pronounced
differences in women.
Joint analyses of smoking and other risk factors, namely
H. pylori infection, contributing to gastric cancer burden
have only been conducted in countries where data on the
prevalence of these two risk factors are widely available,
namely the USA [28]. Such an approach, however, is
highly dependent on the availability of a large amount of
data on trends in the exposure to the risk factors. Therefore,
Fig. 2 Estimates of PAFs (quartiles of the distributions among men and women were used as cutoffs) in 118 countries (countries with no PAF
estimates are presented in white), in 2012, among men and women
Dig Dis Sci (2015) 60:2470–2476 2473
123
computing joint PAFs for H. pylori infection and smoking
would limit our analyses to a much smaller number of
countries, most of them in the very high HDI level, pre-
cluding the identification of geographical areas where ef-
forts to reduce gastric cancer burden through the control of
smoking should be enhanced.
Downward trends in the prevalence of smoking have
been observed worldwide [29], which explain the predicted
decrease in PAFs from 2012 to 2020 in most settings.
Nevertheless, the variation in the estimates was heteroge-
neous, with increases in PAFs being estimated for a
relatively large number of countries. The absolute number
of cases may be expected to increase in countries with
higher PAF estimates in 2020 as well as in those with more
modest declines in PAFs after 2012; among the latter, the
magnitude of the decline in PAFs may be insufficient to
overcome the increase in the number of cases due to
population growth and aging.
The assumptions underlying valid estimation of PAFs
include a causal relationship between exposure and disease,
and that unbiased and free from confounding RR estimates
are available, for the relation between the exposure and the
outcome. Regarding the causal role of smoking in gastric
carcinogenesis, in 2004, the International Agency for Re-
search on Cancer classified tobacco smoking as carcino-
genic to humans, concluding that there was sufficient
evidence that it causes gastric cancer [12]. This evaluation
was based on cohort, case–control, and cross-sectional
studies conducted in various parts of the world showing a
consistent association between smoking and gastric cancer
and also presented data regarding the intensity and duration
of smoking, smoking cessation, and the effect on gastric
cancer precursor lesions. Although residual confounding
cannot be ruled out, it is unlikely that control for the effects
of potentially major confounders, other than H. pylori in-
fection and dietary factors, has not been accomplished. For
the present study, we used the best available evidence on
Fig. 3 Estimates of PAFs according to HDI (HDI distribution in
2012 was retrieved from the Human Development Report, 2013 [25]:
42, 33, 25, and 18 countries with very high, high, medium, and low
HDI, respectively), in 2012, among men and women
Fig. 4 Relation between the variation in the estimated PAFs and in
the number gastric cancer cases attributable to smoking, between
2012 and 2020, according to HDI (HDI distribution in 2012 was
retrieved from the Human Development Report, 2013 [25]: 42, 33,
25, and 18 countries with very high, high, medium, and low HDI,
respectively), among men and women
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the association between smoking and gastric cancer, ob-
tained from the most recent meta-analysis of cohort studies
[15].
Regarding the validity of the RR estimates for the as-
sociation between smoking and gastric cancer, these were
retrieved from a meta-analysis of cohort studies, for which
lower summary estimates were obtained (1.53 [15] for both
sexes) compared with other study designs, such as case–
control studies (1.69 [18] for both sexes). In addition, the
summary estimates from the meta-analysis were based on a
mixture of crude and adjusted RRs, with summary esti-
mates being higher when based solely on adjusted RRs
[15]. Taken together, these may have contributed to con-
servative PAF estimates, though not compromising the
comparison across regions. To further improve the accu-
racy of our estimates of PAF, we used sex-specific sum-
mary RRs, to account for differences in the patterns of
smoking between men and women, and we assumed a time
lag of approximately 10 years between exposure to
smoking and occurrence of cancer, which is supported by
the available evidence on the relation between smoking and
gastric cancer precursor lesions [16]. This may have con-
tributed to more accurate estimates of the burden of gastric
cancer attributable to smoking than in previous studies,
which took into account a smaller [21] or no lag time [26].
Lauren’s [30] classification system has been widely used
in epidemiological research, subdividing tumors into two
main histological types—diffuse and intestinal. Although
originally a relatively greater impact of environmental
factors in the etiology of intestinal-type carcinomas was
hypothesized [31], while the diffuse type was considered
more dependent on the individuals’ genetic profile [32], the
currently available evidence shows no substantial etiolo-
gical differences between these tumors. Despite few studies
addressing the effect of environmental exposures on the
risk of specific gastric cancer histological types, small
differences in the magnitude of the association between
smoking and gastric cancer according to histological type
have been observed, generally with the intestinal type
showing higher risk estimates [33–35]. However, when
finer markers of intestinal differentiation, such as CDX2
expression, are used, no statistically significant or consis-
tent associations between environmental exposures and
CDX2 expression status are observed, suggesting that
gastric cancer subtypes are essentially homogeneous re-
garding the relation with most of the established determi-
nants [36]. Furthermore, the lack of worldwide gastric
cancer incidence estimates according to histological type
precludes the quantification of the effect of smoking in
gastric cancer subtypes at the international level.
Systematic reviews have also shown no meaningful
differences in the magnitude of the association between
current smoking and cardia and non-cardia gastric cancer
[15, 18]; nevertheless, point estimates for the RR are higher
for cardia cancers compared with non-cardia. This may
have contributed to the country-specific PAFs computed in
this study to be underestimated in countries where a higher
proportion of cardia cancers is observed (e.g., Australia,
Finland, USA, UK) and overestimated in countries where
cardia cancers represent a small proportion of all gastric
cancers (e.g., Japan, Russia) [4].
The accuracy of PAF estimates is also dependent on the
quality of the data obtained from each source, and the use
of current smoking prevalence has some limitations.
Although smoking prevalence was obtained mainly from
national surveys conducted within each country, different
methodologies may have been adopted across studies,
namely regarding age group restriction and definition of
current smoking. Furthermore, the accumulated hazards of
smoking for cancers, which have relatively long latency,
depend on the age at which smoking began, duration of
smoking, number of cigarettes smoked per day, and type of
tobacco product used (cigarettes, cigars, bidis, etc.). These
limitations may have contributed to inaccuracies in the
individual estimates, but are unlikely to compromise the
definition of general patterns, particularly with respect to
differences across genders, geographical regions, levels of
HDI, and between 2012 and 2020.
Gastric cancer is currently interpreted as a multifactorial
complex disease, and therefore, different sets of causal
mechanisms leading to its occurrence may coexist [11].
Under this assumption, the same exposure (e.g., smoking)
may contribute to the incidence of gastric cancer when
occurring together with different sets of other exposures
(e.g., H. pylori infection or H. pylori infection and fruit
consumption or H. pylori infection and salt intake). Though
the different causal mechanisms potentially leading to
gastric cancer are not known, the estimated PAFs reflect a
scenario where smoking is not present, therefore affecting
all of the possible pathways to cancer, regardless of the
persistence by the remaining exposures that take part in
those causal mechanisms. Therefore, our results provide
information on the importance of smoking as a cause of
gastric cancer, and the comparison between 2012 and 2020
estimates shows how improvements in tobacco control
strategies may gradually contribute to reduce the burden of
gastric cancer. However, our estimates do not correspond
to realistically attainable objectives through public health
interventions, since a scenario with a 0 % prevalence of
smoking is unlikely.
In conclusion, smoking accounts for a much larger
number of gastric cancer cases among men, and this
number is expected to increase in the next decade, despite
the decrease in PAFs. Intensified efforts to control smok-
ing are needed to further reduce the burden of gastric
cancer.
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